Absolutely - the moment BM sees success in the data (especially if success is seen in cancers typically resistant to ICI) they will make their move.
The question is whether the transaction will look like a licence, sale of the drug or full takeover? I know that's getting a little ahead of myself but NOX has a BD team in place so they must be thinking about these things...
Absolutely - the moment BM sees success in the data (especially...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.22M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.0¢ | $11.03K | 105.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 418372 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 102513 | 3 |
View Market Depth
| Last trade - 15.45pm 27/09/2024 (20 minute delay) ? |
| NOX (ASX) Chart |